_id
691856443c536f8df2317997
Ticker
0HOY.LSE
Name
Boston Scientific Corp.
Exchange
LSE
Address
300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234
Country
UK
Sector
Industry
Currency
USD
Website
https://www.bostonscientific.com
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Last Close
98.59
Volume
10
Current Price
98.7
Change
-0.2028
Last Updated
2026-01-08T13:54:19.225Z
Image
https://logo.clearbit.com/www.bostonscientific.com
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
5065000000
Cost Of Revenue
1523000000
Gross Profit
3542000000
Operating Expenses
2492000000
Operating Income
1050000000
Interest Expense
87000000
Pretax Income
939000000
Net Income
755000000
Eps
0.5048478769642261
Dividends Per Share
-
Shares Outstanding
1383800064
Income Tax Expense
183000000
EBITDA
1026000000
Operating Margin
20.73050345508391
Total Other Income Expense Net
-111000000
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
1.8602
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
1
Health Score
54
Deep Value Investing Score
3
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
4
Garp Investing Score
0.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
5065000000
Quarters > 0 > income Statement > cost Of Revenue
1523000000
Quarters > 0 > income Statement > gross Profit
3542000000
Quarters > 0 > income Statement > operating Expenses
2492000000
Quarters > 0 > income Statement > operating Income
1050000000
Quarters > 0 > income Statement > interest Expense
87000000
Quarters > 0 > income Statement > pretax Income
939000000
Quarters > 0 > income Statement > net Income
755000000
Quarters > 0 > income Statement > eps
0.5048478769642261
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1495500000
Quarters > 0 > income Statement > income Tax Expense
183000000
Quarters > 0 > income Statement > EBITDA
1026000000
Quarters > 0 > income Statement > operating Margin
20.73050345508391
Quarters > 0 > income Statement > total Other Income Expense Net
-111000000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.5048478769642261
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
54
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5061000000
Quarters > 1 > income Statement > cost Of Revenue
1637000000
Quarters > 1 > income Statement > gross Profit
3424000000
Quarters > 1 > income Statement > operating Expenses
2481000000
Quarters > 1 > income Statement > operating Income
943000000
Quarters > 1 > income Statement > interest Expense
90000000
Quarters > 1 > income Statement > pretax Income
941000000
Quarters > 1 > income Statement > net Income
793000000
Quarters > 1 > income Statement > eps
0.530967525945765
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1493500000
Quarters > 1 > income Statement > income Tax Expense
146000000
Quarters > 1 > income Statement > EBITDA
1368000000
Quarters > 1 > income Statement > operating Margin
18.63268128828295
Quarters > 1 > income Statement > total Other Income Expense Net
-2000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
534000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2815000000
Quarters > 1 > balance Sheet > inventories
2861000000
Quarters > 1 > balance Sheet > total Current Assets
7121000000
Quarters > 1 > balance Sheet > property Plant Equipment
3953000000
Quarters > 1 > balance Sheet > total Assets
41559000000
Quarters > 1 > balance Sheet > payables
962000000
Quarters > 1 > balance Sheet > short Term Debt
480000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
18906000000
Quarters > 1 > balance Sheet > equity
22418000000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
797000000
Quarters > 1 > cash Flow > depreciation
336000000
Quarters > 1 > cash Flow > change In Working Capital
2000000
Quarters > 1 > cash Flow > cash From Operations
1286000000
Quarters > 1 > cash Flow > capital Expenditures
157000000
Quarters > 1 > cash Flow > cash From Investing
-1126000000
Quarters > 1 > cash Flow > cash From Financing
-340000000
Quarters > 1 > cash Flow > net Change In Cash
-178000000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.530967525945765
Quarters > 1 > ratios > PB
6.575450530823446
Quarters > 1 > ratios > ROE
3.537336069230083
Quarters > 1 > ratios > ROA
1.908130609494935
Quarters > 1 > ratios > FCF
1129000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.22307844299545546
Quarters > 1 > health Score
62
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
4663000000
Quarters > 2 > income Statement > cost Of Revenue
1713000000
Quarters > 2 > income Statement > gross Profit
2950000000
Quarters > 2 > income Statement > operating Expenses
2054000000
Quarters > 2 > income Statement > operating Income
896000000
Quarters > 2 > income Statement > interest Expense
82000000
Quarters > 2 > income Statement > pretax Income
805000000
Quarters > 2 > income Statement > net Income
674000000
Quarters > 2 > income Statement > eps
0.4514098184984261
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1493100000
Quarters > 2 > income Statement > income Tax Expense
133000000
Quarters > 2 > income Statement > EBITDA
1217000000
Quarters > 2 > income Statement > operating Margin
19.215097576667382
Quarters > 2 > income Statement > total Other Income Expense Net
-91000000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
725000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2693000000
Quarters > 2 > balance Sheet > inventories
2867000000
Quarters > 2 > balance Sheet > total Current Assets
7335000000
Quarters > 2 > balance Sheet > property Plant Equipment
3837000000
Quarters > 2 > balance Sheet > total Assets
40140000000
Quarters > 2 > balance Sheet > payables
1004000000
Quarters > 2 > balance Sheet > short Term Debt
777000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
17695000000
Quarters > 2 > balance Sheet > equity
22212000000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
674000000
Quarters > 2 > cash Flow > depreciation
325000000
Quarters > 2 > cash Flow > change In Working Capital
-678000000
Quarters > 2 > cash Flow > cash From Operations
541000000
Quarters > 2 > cash Flow > capital Expenditures
187000000
Quarters > 2 > cash Flow > cash From Investing
-500000000
Quarters > 2 > cash Flow > cash From Financing
233000000
Quarters > 2 > cash Flow > net Change In Cash
313000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.4514098184984261
Quarters > 2 > ratios > PB
6.634655591572123
Quarters > 2 > ratios > ROE
3.034395822078156
Quarters > 2 > ratios > ROA
1.6791230692575982
Quarters > 2 > ratios > FCF
354000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.07591679176495818
Quarters > 2 > health Score
48
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4561000000
Quarters > 3 > income Statement > cost Of Revenue
1890000000
Quarters > 3 > income Statement > gross Profit
2671000000
Quarters > 3 > income Statement > operating Expenses
2082000000
Quarters > 3 > income Statement > operating Income
589000000
Quarters > 3 > income Statement > interest Expense
139000000
Quarters > 3 > income Statement > pretax Income
585000000
Quarters > 3 > income Statement > net Income
566000000
Quarters > 3 > income Statement > eps
0.37981478996107904
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1490200000
Quarters > 3 > income Statement > income Tax Expense
23000000
Quarters > 3 > income Statement > EBITDA
1071000000
Quarters > 3 > income Statement > operating Margin
12.913834685376013
Quarters > 3 > income Statement > total Other Income Expense Net
-4000000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
525000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2558000000
Quarters > 3 > balance Sheet > inventories
2810000000
Quarters > 3 > balance Sheet > total Current Assets
6920000000
Quarters > 3 > balance Sheet > property Plant Equipment
3743000000
Quarters > 3 > balance Sheet > total Assets
39395000000
Quarters > 3 > balance Sheet > payables
960000000
Quarters > 3 > balance Sheet > short Term Debt
1859000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
17392000000
Quarters > 3 > balance Sheet > equity
21770000000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
566000000
Quarters > 3 > cash Flow > depreciation
348000000
Quarters > 3 > cash Flow > change In Working Capital
324000000
Quarters > 3 > cash Flow > cash From Operations
1456000000
Quarters > 3 > cash Flow > capital Expenditures
277000000
Quarters > 3 > cash Flow > cash From Investing
-3704000000
Quarters > 3 > cash Flow > cash From Financing
214000000
Quarters > 3 > cash Flow > net Change In Cash
-2047000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.37981478996107904
Quarters > 3 > ratios > PB
6.756212218649519
Quarters > 3 > ratios > ROE
2.599908130454754
Quarters > 3 > ratios > ROA
1.4367305495621272
Quarters > 3 > ratios > FCF
1179000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2584959438719579
Quarters > 3 > health Score
61
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
16747000000
Annuals > 0 > income Statement > cost Of Revenue
6480000000
Annuals > 0 > income Statement > gross Profit
10267000000
Annuals > 0 > income Statement > operating Expenses
7632000000
Annuals > 0 > income Statement > operating Income
2635000000
Annuals > 0 > income Statement > interest Expense
387000000
Annuals > 0 > income Statement > pretax Income
2282000000
Annuals > 0 > income Statement > net Income
1854000000
Annuals > 0 > income Statement > eps
1.2477286493034525
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1485900000
Annuals > 0 > income Statement > income Tax Expense
436000000
Annuals > 0 > income Statement > EBITDA
3940000000
Annuals > 0 > income Statement > operating Margin
15.734161342329969
Annuals > 0 > income Statement > total Other Income Expense Net
-353000000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
525000000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2558000000
Annuals > 0 > balance Sheet > inventories
2810000000
Annuals > 0 > balance Sheet > total Current Assets
6920000000
Annuals > 0 > balance Sheet > property Plant Equipment
3743000000
Annuals > 0 > balance Sheet > total Assets
39395000000
Annuals > 0 > balance Sheet > payables
960000000
Annuals > 0 > balance Sheet > short Term Debt
1859000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
17392000000
Annuals > 0 > balance Sheet > equity
21770000000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
1854000000
Annuals > 0 > cash Flow > depreciation
1269000000
Annuals > 0 > cash Flow > change In Working Capital
-462000000
Annuals > 0 > cash Flow > cash From Operations
3435000000
Annuals > 0 > cash Flow > capital Expenditures
790000000
Annuals > 0 > cash Flow > cash From Investing
-5687000000
Annuals > 0 > cash Flow > cash From Financing
1814000000
Annuals > 0 > cash Flow > net Change In Cash
-470000000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
1.2477286493034525
Annuals > 0 > ratios > PB
6.7367170418006435
Annuals > 0 > ratios > ROE
8.516306844281122
Annuals > 0 > ratios > ROA
4.706180987434953
Annuals > 0 > ratios > FCF
2645000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.15793873529587388
Annuals > 0 > health Score
64
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
14240000000
Annuals > 1 > income Statement > cost Of Revenue
4391000000
Annuals > 1 > income Statement > gross Profit
9849000000
Annuals > 1 > income Statement > operating Expenses
7506000000
Annuals > 1 > income Statement > operating Income
2343000000
Annuals > 1 > income Statement > interest Expense
272000000
Annuals > 1 > income Statement > pretax Income
1984000000
Annuals > 1 > income Statement > net Income
1593000000
Annuals > 1 > income Statement > eps
1.0884865049538777
Annuals > 1 > income Statement > dividends Per Share
28000000
Annuals > 1 > income Statement > shares Outstanding
1463500000
Annuals > 1 > income Statement > income Tax Expense
393000000
Annuals > 1 > income Statement > EBITDA
3613000000
Annuals > 1 > income Statement > operating Margin
16.453651685393258
Annuals > 1 > income Statement > total Other Income Expense Net
-359000000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
865000000
Annuals > 1 > balance Sheet > short Term Investments
130000000
Annuals > 1 > balance Sheet > receivables
2228000000
Annuals > 1 > balance Sheet > inventories
2484000000
Annuals > 1 > balance Sheet > total Current Assets
6514000000
Annuals > 1 > balance Sheet > property Plant Equipment
3298000000
Annuals > 1 > balance Sheet > total Assets
35136000000
Annuals > 1 > balance Sheet > payables
942000000
Annuals > 1 > balance Sheet > short Term Debt
607000000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
15606000000
Annuals > 1 > balance Sheet > equity
19282000000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
1592000000
Annuals > 1 > cash Flow > depreciation
1196000000
Annuals > 1 > cash Flow > change In Working Capital
-770000000
Annuals > 1 > cash Flow > cash From Operations
2503000000
Annuals > 1 > cash Flow > capital Expenditures
711000000
Annuals > 1 > cash Flow > cash From Investing
-2574000000
Annuals > 1 > cash Flow > cash From Financing
5000000
Annuals > 1 > cash Flow > net Change In Cash
-71000000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
1.0884865049538777
Annuals > 1 > ratios > PB
7.491310548698268
Annuals > 1 > ratios > ROE
8.261591121252982
Annuals > 1 > ratios > ROA
4.533811475409836
Annuals > 1 > ratios > FCF
1792000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.1258426966292135
Annuals > 1 > health Score
61
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
12682000000
Annuals > 2 > income Statement > cost Of Revenue
4968000000
Annuals > 2 > income Statement > gross Profit
7714000000
Annuals > 2 > income Statement > operating Expenses
5890000000
Annuals > 2 > income Statement > operating Income
1824000000
Annuals > 2 > income Statement > interest Expense
464000000
Annuals > 2 > income Statement > pretax Income
1141000000
Annuals > 2 > income Statement > net Income
698000000
Annuals > 2 > income Statement > eps
0.4848232270611933
Annuals > 2 > income Statement > dividends Per Share
55000000
Annuals > 2 > income Statement > shares Outstanding
1439700000
Annuals > 2 > income Statement > income Tax Expense
443000000
Annuals > 2 > income Statement > EBITDA
2741000000
Annuals > 2 > income Statement > operating Margin
14.382589496924775
Annuals > 2 > income Statement > total Other Income Expense Net
-683000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1077000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1970000000
Annuals > 2 > balance Sheet > inventories
1867000000
Annuals > 2 > balance Sheet > total Current Assets
5760000000
Annuals > 2 > balance Sheet > property Plant Equipment
2832000000
Annuals > 2 > balance Sheet > total Assets
32469000000
Annuals > 2 > balance Sheet > payables
862000000
Annuals > 2 > balance Sheet > short Term Debt
81000000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
14896000000
Annuals > 2 > balance Sheet > equity
17573000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
698000000
Annuals > 2 > cash Flow > depreciation
1136000000
Annuals > 2 > cash Flow > change In Working Capital
-541000000
Annuals > 2 > cash Flow > cash From Operations
1526000000
Annuals > 2 > cash Flow > capital Expenditures
588000000
Annuals > 2 > cash Flow > cash From Investing
-2011000000
Annuals > 2 > cash Flow > cash From Financing
-548000000
Annuals > 2 > cash Flow > net Change In Cash
-1042000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.4848232270611933
Annuals > 2 > ratios > PB
8.086177089853752
Annuals > 2 > ratios > ROE
3.9720025038411197
Annuals > 2 > ratios > ROA
2.149742831624011
Annuals > 2 > ratios > FCF
938000000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.07396309730326447
Annuals > 2 > health Score
49
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
11888000000
Annuals > 3 > income Statement > cost Of Revenue
4427000000
Annuals > 3 > income Statement > gross Profit
7461000000
Annuals > 3 > income Statement > operating Expenses
5539000000
Annuals > 3 > income Statement > operating Income
1922000000
Annuals > 3 > income Statement > interest Expense
349000000
Annuals > 3 > income Statement > pretax Income
1076000000
Annuals > 3 > income Statement > net Income
1040000000
Annuals > 3 > income Statement > eps
0.7253452364346492
Annuals > 3 > income Statement > dividends Per Share
55000000
Annuals > 3 > income Statement > shares Outstanding
1433800000
Annuals > 3 > income Statement > income Tax Expense
36000000
Annuals > 3 > income Statement > EBITDA
2917000000
Annuals > 3 > income Statement > operating Margin
16.167563930013458
Annuals > 3 > income Statement > total Other Income Expense Net
-846000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2113000000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1778000000
Annuals > 3 > balance Sheet > inventories
1610000000
Annuals > 3 > balance Sheet > total Current Assets
6317000000
Annuals > 3 > balance Sheet > property Plant Equipment
2687000000
Annuals > 3 > balance Sheet > total Assets
32229000000
Annuals > 3 > balance Sheet > payables
794000000
Annuals > 3 > balance Sheet > short Term Debt
332000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
15607000000
Annuals > 3 > balance Sheet > equity
16622000000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
1041000000
Annuals > 3 > cash Flow > depreciation
1093000000
Annuals > 3 > cash Flow > change In Working Capital
-625000000
Annuals > 3 > cash Flow > cash From Operations
1870000000
Annuals > 3 > cash Flow > capital Expenditures
554000000
Annuals > 3 > cash Flow > cash From Investing
-1597000000
Annuals > 3 > cash Flow > cash From Financing
-95000000
Annuals > 3 > cash Flow > net Change In Cash
173000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.7253452364346492
Annuals > 3 > ratios > PB
8.513780531825292
Annuals > 3 > ratios > ROE
6.256768138611479
Annuals > 3 > ratios > ROA
3.22690744360669
Annuals > 3 > ratios > FCF
1316000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.11069986541049798
Annuals > 3 > health Score
56
Valuation > metrics > PE
1.8602
Valuation > final Score
70
Valuation > verdict
81.4% Undervalued
Profitability > metrics > Net Margin
0.14906219151036526
Profitability > final Score
57
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
12.068965517241379
Risk > final Score
70
Risk > verdict
Low
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
61
Prev Profitabilities > 1
55
Prev Profitabilities > 2
48
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
65
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:53:33.992Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-21
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-04
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
0.78
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-22
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.5048
Earnings History > 2 > eps Estimate
0.71
Earnings History > 2 > eps Difference
-0.2052
Earnings History > 2 > surprise Percent
-28.9014
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-07-23
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.5336
Earnings History > 3 > eps Estimate
0.73
Earnings History > 3 > eps Difference
-0.1964
Earnings History > 3 > surprise Percent
-26.9041
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-04-23
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.4514
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-05
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.3798
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-23
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.3153
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-07-24
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0.2183
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-04-24
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.3341
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-06
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.3413
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-10-26
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0.3424
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-07-27
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0.1792
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-04-26
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
0.2075
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2023-02-01
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
0.0874
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-10-26
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
0.1208
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-07-27
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0.1711
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-04-27
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0.0674
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2022-02-02
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
0.0557
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-10-27
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
0.2821
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-07-27
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
0.1201
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-04-28
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
0.2285
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
0.0958
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.1181
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.1084
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
0.0078
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
2.8278
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
0.0892
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
0.1093
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
0.3011
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-12-31
Earnings History > 29 > report Date
2018-12-31
Earnings History > 29 > date
2018-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
0.2745
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-09-30
Earnings History > 30 > report Date
2018-09-30
Earnings History > 30 > date
2018-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
0.3077
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-06-30
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
0.3967
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2018-03-31
Earnings History > 32 > report Date
2018-03-31
Earnings History > 32 > date
2018-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
0.2133
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of Boston Scientific Corp.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.78
Date
2025-09-30
EPS Actual
0.5048
EPS Estimate
0.71
EPS Difference
-0.2052
Surprise Percent
-28.9014%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.